Expertise

The landscape of Oncology in Asia-Pacific Biotechnology companies are facing increased challenges around participant recruitment and rete

Our team can assist in all clinical study phases and in study designs ranging from first in human, single ascending dose, multiple ascending dose, drug-drug interaction, bioavailability/bioequivalence, food effect and special population studies.

Novotech Drug Development Consulting is a full-service global product development and strategic regulatory group, providing comprehensive “lab to launch” program development services.

Novotech initiated the first national, privately owned, commercial Institutional Biosafety Committee (IBC) in Australia, successfully accredited b

The landscape of Liver diseases in Asia-Pacific Biotechnology companies consider locations in the Asia-Pacific region, s

Providing Infectious diseases services and Vaccines CRO services Many biotechnology companies look at the Asia-Pacific region for their t

Many biotechnology companies come to Australia to conduct early phase clinical trials and take advantage of straightforward regulatory streams and